Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 26;10:1405.
doi: 10.3389/fimmu.2019.01405. eCollection 2019.

Podocytes and Proteinuria in ANCA-Associated Glomerulonephritis: A Case-Control Study

Free PMC article

Podocytes and Proteinuria in ANCA-Associated Glomerulonephritis: A Case-Control Study

Emma E van Daalen et al. Front Immunol. .
Free PMC article


Proteinuria has been identified as prognosticator of renal outcome in patients with ANCA-associated glomerulonephritis, but whether proteinuria is related to podocyte abnormalities in these patients is largely unknown. We here investigate podocyte foot process width and number of podocytes positive for the podocyte marker WT-1 in diagnostic renal biopsies of 25 Caucasian patients with ANCA-associated glomerulonephritis in relation to proteinuria. Control tissue was used from pre-transplantation donor kidney biopsies. Proteinuria at 10 weeks follow-up correlated significantly with foot process width (P = 0.04). Biopsies with foot process width ≥600 nm belonged more often to the crescentic or mixed class, whereas biopsies with a foot process width <600 nm were most often categorized as focal class (P = 0.03). The mean number of podocytes based upon expression of WT-1 was significantly lower in patients compared to controls (15 vs. 34 podocytes per glomerulus; P < 0.0001). The significant decrease in expression of the podocyte WT-1 marker in ANCA-associated glomerulonephritis is considered indicative of actual podocyte loss or at least, of a loss of functionality. Furthermore, our study indicates that podocyte foot process width at baseline could be indicative for proteinuria at short term follow up. For prognostic purposes, we therefore suggest to include a description of the foot process width in the diagnostic report of a biopsy with ANCA-associated glomerulonephritis.

Keywords: ANCA; podocyte; proteinuria; renal biopsy; vasculitis.


Figure 1
Figure 1
Examples of EM pictures used to calculate FPW (magnification 10.000-fold). (A) EM picture of a patient with AAGN showing foot process effacement (part of the effacement is pointed by arrows). (B) EM picture of a control with normal foot processes.
Figure 2
Figure 2
Course of patients' individual 24-h proteinuria levels during follow-up. (A) Proteinuria levels during 10 weeks of follow-up. (B) Proteinuria levels during 400 days of follow-up.
Figure 3
Figure 3
Podocytes positive for WT-1. (A) WT-1 staining in a glomerulus of a patient with AAGN. (B) WT-1 staining in a glomerulus of a control. Asterisks (*) indicate a podocyte positive for WT-1. (C) Number of podocytes per glomerulus in controls and in patients (P < 0.0001). (D) Number of nuclei per glomerulus in controls and in patients.

Similar articles

See all similar articles


    1. Cordova-Sanchez BM, Mejia-Vilet JM, Morales-Buenrostro LE, Loyola-Rodriguez G, Uribe-Uribe NO, Correa-Rotter R. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol. (2016) 35:1805–16. 10.1007/s10067-016-3195-z - DOI - PubMed
    1. Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT. Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant. (2005) 20:96–104. 10.1093/ndt/gfh563 - DOI - PubMed
    1. Franssen CF, Stegeman CA, Oost-Kort WW, Kallenberg CG, Limburg PC, Tiebosch A, et al. . Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol. (1998) 9:1915–23. - PubMed
    1. Karras A, Hiemstra TF, Jones RB, Jayne D. Prognostic value of persistent heamaturia and proteinuria in ANCA-Associated Vasculitis: Data from the European Vasculitis Study Group (EUVAS) therapeutic trials. J Am Soc Nephrol. (2015) 26:447A 10.1038/kisup.2012.73 - DOI
    1. Hilhorst M, Wilde B, van Breda Vriesman P, van Paassen P, Cohen Tervaert JW. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol. (2013) 24:1371–5. 10.1681/ASN.2012090912 - DOI - PMC - PubMed

Publication types

LinkOut - more resources